文献速递妇科生殖医学

LINC01638通过抑制HDAC1上调RHOB促进子宫内膜异位症上皮细胞上皮-间质转化

LINC01638 promotes epithelial-to-mesenchymal transition in endometriosis epithelial cells by up-regulating RHOB via HDAC1 suppression.
PubMed 文献 · Reprod Biomed Online · 2025-03-14

前瞻性患者队列结合12Z子宫内膜异位症上皮细胞功能实验,探讨LINC01638在子宫内膜异位症上皮-间质转化中的作用。24例对照和41例子宫内膜异位症患者的在位内膜和异位病灶样本显示,LINC01638在异位病灶上皮层上调,敲低后12Z细胞增殖、黏附、迁移和侵袭减少,与p21、p27表达增加和G1期阻滞相关。LINC01638通过HDAC1介导的启动子去乙酰化调控RHOB表达,RHOB在异位病灶上皮层较在位内膜上调。

要点

  • LINC01638在子宫内膜异位症异位病灶上皮层上调。
  • 敲低LINC01638减少12Z细胞增殖、黏附、迁移和侵袭,伴p21、p27升高和G1期阻滞。
  • LINC01638通过HDAC1介导的启动子去乙酰化调控RHOB表达。

核心结论

  • LINC01638是子宫内膜异位症发病机制中的表观遗传调控因子,促进异位病灶增殖和上皮-间质转化。

研究设计与样本

  • 前瞻性患者队列研究结合12Z子宫内膜异位症上皮细胞系功能实验。
  • 通过刮宫收集在位内膜样本,通过腹腔镜手术收集异位内膜病灶样本,来自24例对照患者和41例子宫内膜异位症患者。
  • 使用siRNA敲低LINC01638后,进行增殖、黏附、迁移和侵袭实验,并用流式细胞术评估凋亡和细胞周期变化。
  • 将LINC01638敲低与特异性HDAC抑制剂罗米地辛抑制HDAC联合,评估LINC01638与组蛋白去乙酰化酶1类酶(HDAC1)的关系。

主要发现

  • LINC01638在子宫内膜异位病灶上皮层上调。
  • 12Z细胞中敲低LINC01638导致增殖、黏附、迁移和侵袭减少。
  • 增殖减少与p21和p27表达增加及G1期阻滞相关。
  • 敲低细胞中多个与上皮-间质转化相关的转录因子下调,细胞骨架调控基因RHOB下调,而HDAC1上调。
  • 染色质免疫沉淀分析和HDAC1抑制联合LINC01638敲低表明,LINC01638通过HDAC1介导的启动子去乙酰化调控RHOB表达。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Is LINC01638 involved in regulation of epithelial-to-mesenchymal transition (EMT) in endometriosis? DESIGN: A prospective patient cohort study was combined with functional experiments in the 12Z endometriosis epithelial cell line to investigate the role of LINC01638 in endometriosis. Eutopic endometrial samples were collected by curettage, and ectopic endometrial lesion samples were collected by laparoscopic surgery from 24 control patients and 41 patients with endometriosis. The phenotype of 12Z cells was assessed following LINC01638 knockdown using siRNA, performing proliferation, adhesion, migration and invasion assays, as well as assessing apoptosis and cell cycle changes with flow cytometry assays. In order to assess the relationship between LINC01638 and histone deacetylase class 1 enzyme (HDAC1), LINC01638 knockdown was combined with HDAC inhibition with the specific HDAC inhibitor romidepsin. RESULTS: LINC01638 was up-regulated in the epithelial layer of endometriotic lesions, and LINC01638 knockdown in 12Z cells led to reduced proliferation, adhesion, migration and invasion. The reduction in proliferation was associated with increased p21 and p27 expression, and G1 phase arrest. Further analysis of LINC01638 control and knockdown cells revealed that a number of transcription factors associated with EMT are down-regulated in knockdown cells, along with the cytoskeleton regulatory gene RHOB, while HDAC1 was up-regulated. Chromatin immunoprecipitation analysis and HDAC1 inhibitory treatment combined with LINC01638 knockdown indicated that LINC01638 regulates RHOB expression via HDAC1-mediated promoter deacetylation. RHOB is up-regulated in the epithelial layer of endometriotic lesions compared with eutopic endometrium, supporting a role in the disease. CONCLUSIONS: LINC01638 is an epigenetic regulator of the pathogenesis of endometriosis, promoting proliferation and EMT of endometriotic lesions.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Yotova I, Proestling K, Pauler FM, et al. LINC01638 promotes epithelial-to-mesenchymal transition in endometriosis epithelial cells by up-regulating RHOB via HDAC1 suppression. Reprod Biomed Online. 2025. PMID: 40680553. doi:10.1016/j.rbmo.2025.104942

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。